PROBIOTIX HEALTH LS-05 (X90) — Working Capital to Net Assets Ratio
PROBIOTIX HEALTH LS-05 (X90) has a Working Capital to Net Assets ratio of 90.8% as of June 2025. Working capital of €1.62 Million (current assets of €2.16 Million minus current liabilities of €538.00K) is measured against net assets of €1.79 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See X90 financial flexibility score to measure the company's free cash flow as a share of total liabilities.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
PROBIOTIX HEALTH LS-05 Working Capital to Net Assets (2022–2024)
This chart shows how PROBIOTIX HEALTH LS-05's Working Capital to Net Assets ratio has evolved across 3 annual periods from 2022 to 2024. As of June 2025, the ratio stands at 90.8%, reflecting working capital of €1.62 Million against net assets of €1.79 Million EUR. See PROBIOTIX HEALTH LS-05 (X90) liquidity interval to measure how many days the company can operate on defensive assets alone.
Annual Working Capital to Net Assets for PROBIOTIX HEALTH LS-05 (2022–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for PROBIOTIX HEALTH LS-05 from 2022 to 2024, covering 3 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see PROBIOTIX HEALTH LS-05 (X90) market capitalisation.
| Year | WC/NA Ratio | Working Capital (EUR) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 90.5% | €1.74 Million | €1.92 Million | €1.93 Million | €194.00K | ▲ +5.2 pp |
| 2023 | 85.2% | €1.30 Million | €1.53 Million | €1.87 Million | €566.00K | ▼ -2.8 pp |
| 2022 | 88.0% | €1.75 Million | €1.99 Million | €2.02 Million | €272.04K | — |